These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 10816494

  • 21. Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation.
    Lüder CG, Giraldo-Velásquez M, Sendtner M, Gross U.
    Exp Parasitol; 1999 Sep; 93(1):23-32. PubMed ID: 10464035
    [Abstract] [Full Text] [Related]

  • 22. Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha.
    Däubener W, Remscheid C, Nockemann S, Pilz K, Seghrouchni S, Mackenzie C, Hadding U.
    Eur J Immunol; 1996 Feb; 26(2):487-92. PubMed ID: 8617321
    [Abstract] [Full Text] [Related]

  • 23. CD40 signaling in macrophages induces activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates.
    Andrade RM, Portillo JA, Wessendarp M, Subauste CS.
    Infect Immun; 2005 May; 73(5):3115-23. PubMed ID: 15845519
    [Abstract] [Full Text] [Related]

  • 24. Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-gamma and TNF-alpha.
    Beaman MH, Hunter CA, Remington JS.
    J Immunol; 1994 Nov 15; 153(10):4583-7. PubMed ID: 7963530
    [Abstract] [Full Text] [Related]

  • 25. Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii.
    Schlüter D, Deckert M, Hof H, Frei K.
    Infect Immun; 2001 Dec 15; 69(12):7889-93. PubMed ID: 11705972
    [Abstract] [Full Text] [Related]

  • 26. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
    Yap GS, Sher A.
    J Exp Med; 1999 Apr 05; 189(7):1083-92. PubMed ID: 10190899
    [Abstract] [Full Text] [Related]

  • 27. Role of IDO activation in anti-microbial defense in human native astrocytes.
    Oberdörfer C, Adams O, MacKenzie CR, De Groot CJ, Däubener W.
    Adv Exp Med Biol; 2003 Apr 05; 527():15-26. PubMed ID: 15206712
    [Abstract] [Full Text] [Related]

  • 28. In vitro effect of TNF-alpha and IFN-gamma in retinal cell infection with Toxoplasma gondii.
    Delair E, Creuzet C, Dupouy-Camet J, Roisin MP.
    Invest Ophthalmol Vis Sci; 2009 Apr 05; 50(4):1754-60. PubMed ID: 19321794
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.
    Hunter CA, Subauste CS, Van Cleave VH, Remington JS.
    Infect Immun; 1994 Jul 05; 62(7):2818-24. PubMed ID: 7911785
    [Abstract] [Full Text] [Related]

  • 31. Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages.
    Lüder CG, Algner M, Lang C, Bleicher N, Gross U.
    Int J Parasitol; 2003 Jul 30; 33(8):833-44. PubMed ID: 12865083
    [Abstract] [Full Text] [Related]

  • 32. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice.
    Khan IA, Matsuura T, Fonseka S, Kasper LH.
    J Immunol; 1996 Jan 15; 156(2):636-43. PubMed ID: 8543815
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The mechanism of interferon-gamma induced anti Toxoplasma gondii by indoleamine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues.
    Fujigaki S, Takemura M, Hamakawa H, Seishima M, Saito K.
    Adv Exp Med Biol; 2003 Jan 15; 527():97-103. PubMed ID: 15206721
    [Abstract] [Full Text] [Related]

  • 35. [Correlation between the dose and the anti-Toxoplasma effect of activated mouse macrophages induced by IFN-gamma and the synergism between IFN-gamma and TNF-alpha].
    Zhang A, Yang H, Yang Y, Qian Z.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998 Jan 15; 16(6):436-40. PubMed ID: 12078289
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cutting Edge: IFN-γ Produced by Brain-Resident Cells Is Crucial To Control Cerebral Infection with Toxoplasma gondii.
    Sa Q, Ochiai E, Tiwari A, Perkins S, Mullins J, Gehman M, Huckle W, Eyestone WH, Saunders TL, Shelton BJ, Suzuki Y.
    J Immunol; 2015 Aug 01; 195(3):796-800. PubMed ID: 26091720
    [Abstract] [Full Text] [Related]

  • 38. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.
    Hunter CA, Chizzonite R, Remington JS.
    J Immunol; 1995 Nov 01; 155(9):4347-54. PubMed ID: 7594594
    [Abstract] [Full Text] [Related]

  • 39. Induction of toxoplasmostasis in a human glioblastoma by interferon gamma.
    Däubener W, Pilz K, Seghrouchni Zennati S, Bilzer T, Fischer HG, Hadding U.
    J Neuroimmunol; 1993 Mar 01; 43(1-2):31-8. PubMed ID: 8384636
    [Abstract] [Full Text] [Related]

  • 40. Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia.
    Rozenfeld C, Martinez R, Seabra S, Sant'anna C, Gonçalves JG, Bozza M, Moura-Neto V, De Souza W.
    Am J Pathol; 2005 Oct 01; 167(4):1021-31. PubMed ID: 16192637
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.